-
公开(公告)号:US11642374B2
公开(公告)日:2023-05-09
申请号:US16182146
申请日:2018-11-06
申请人: REGENTS OF THE UNIVERSITY OF MINNESOTA , INTIMA BIOSCIENCE, INC. , The United States of America, as represented by the Secretary, Department of Health and Human Services
发明人: Branden Moriarity , Beau Webber , Modassir Choudhry , Steven A. Rosenberg , Douglas C. Palmer , Nicholas P. Restifo
IPC分类号: A61P35/00 , A61K35/17 , A61K48/00 , C07K14/715 , C12N15/113 , C07K14/47 , C07K14/725 , C12N5/0783 , C07K14/705 , C12N15/90 , C12N9/22 , C12N9/96 , C12N15/87
CPC分类号: A61K35/17 , C07K14/4718 , C07K14/7051 , C07K14/70503 , C07K14/7158 , C12N5/0636 , C12N9/22 , C12N9/96 , C12N15/113 , C12N15/907 , C12N15/87 , C12N2310/20 , C12N2510/00
摘要: Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.
-
公开(公告)号:US11147837B2
公开(公告)日:2021-10-19
申请号:US15256086
申请日:2016-09-02
申请人: Regents of the University of Minnesota , Intima Bioscience, Inc. , The United States of America, as represented by the Secretary, Department of Health and Human Services
发明人: Branden Moriarity , Beau Webber , Modassir Choudhry , R. Scott McIvor , David Largaespada , Steven A. Rosenberg , Douglas C. Palmer , Nicholas P. Restifo
IPC分类号: A61K35/17 , C07K14/715 , C12N15/113 , C07K14/47 , C07K14/725 , C12N5/0783 , C07K14/705 , C12N15/90 , C12N9/22 , C12N9/96 , C12N15/87
摘要: Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.
-
公开(公告)号:US10166255B2
公开(公告)日:2019-01-01
申请号:US15224151
申请日:2016-07-29
申请人: REGENTS OF THE UNIVERSITY OF MINNESOTA , INTIMA BIOSCIENCE, INC. , The United States of America, as represented by the Secretary, Department of Health and Human Services
发明人: Branden Moriarity , Beau Webber , R. Scott McIvor , Modassir Choudhry , Steven A. Rosenberg , Douglas C. Palmer , Nicholas P. Restifo
IPC分类号: C12N5/10 , C12N15/90 , A61K35/17 , C07K14/47 , C07K14/725 , C12N5/0783 , C07K14/705 , C07K14/715 , C12N9/22 , C12N9/96 , C12N15/113 , C12N15/87
摘要: Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.
-
公开(公告)号:US20220125843A1
公开(公告)日:2022-04-28
申请号:US17478615
申请日:2021-09-17
申请人: Regents of the University of Minnesota , Intima Bioscience, Inc. , The United States of America, as represented by the Secretary, Department of Health and Human Servic
发明人: Branden Moriarity , Beau Webber , Modassir Choudhry , R. Scott McIvor , David Largaespada , Steven A. Rosenberg , Douglas C. Palmer , Nicholas P. Restifo
IPC分类号: A61K35/17 , C07K14/47 , C12N9/22 , C12N9/96 , C07K14/725 , C12N15/90 , C07K14/715 , C12N15/113 , C07K14/705 , C12N5/0783 , C12N15/87
摘要: Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.
-
公开(公告)号:US11642375B2
公开(公告)日:2023-05-09
申请号:US16182189
申请日:2018-11-06
申请人: REGENTS OF THE UNIVERSITY OF MINNESOTA , INTIMA BIOSCIENCE, INC. , The United States of America, as represented by the Secretary, Department of Health and Human Services
发明人: Branden Moriarity , Beau Webber , Modassir Choudhry , Steven A. Rosenberg , Douglas C. Palmer , Nicholas P. Restifo
IPC分类号: A61P35/00 , A61K35/17 , A61K48/00 , C07K14/715 , C12N15/113 , C07K14/47 , C07K14/725 , C12N5/0783 , C07K14/705 , C12N15/90 , C12N9/22 , C12N9/96 , C12N15/87
CPC分类号: A61K35/17 , C07K14/4718 , C07K14/7051 , C07K14/70503 , C07K14/7158 , C12N5/0636 , C12N9/22 , C12N9/96 , C12N15/113 , C12N15/907 , C12N15/87 , C12N2310/20 , C12N2510/00
摘要: Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.
-
公开(公告)号:US10912797B2
公开(公告)日:2021-02-09
申请号:US15947688
申请日:2018-04-06
申请人: REGENTS OF THE UNIVERSITY OF MINNESOTA , INTIMA BIOSCIENCE, INC. , The United States of America, as Represented by the Secretary, Department of Health and Human Services
发明人: Branden Moriarity , Beau Webber , Modassir Choudhry , Steven A. Rosenberg , Douglas C. Palmer , Nicholas P. Restifo
IPC分类号: A61K35/17 , C12N15/113 , C07K14/705 , C07K14/47 , A61P31/00 , A61P35/00 , A61K9/00 , C07K14/725 , C07K14/715 , C12N5/0783 , C12N9/22 , C12N15/79 , C12N15/90 , A61K45/06
摘要: Genetically modified compositions, such as non-viral vectors and tumor infiltrating lymphocytes, for the treatment of gastrointestinal cancer are disclosed. Disclosed are methods of utilizing a CRISPR system to generate genetically modified compositions. Also disclosed are the methods of making and using the genetically modified compositions for the treatment of gastrointestinal cancer.
-
公开(公告)号:US10406177B2
公开(公告)日:2019-09-10
申请号:US15250514
申请日:2016-08-29
申请人: Regents of the University of Minnesota , Intima Bioscience, Inc. , The United States of America, as represented by the Secretary, Department of Health and Human Services
发明人: Branden Moriarity , Beau Webber , Modassir Choudhry , Steven A. Rosenberg , Douglas C. Palmer , Nicholas P. Restifo
IPC分类号: C12N5/00 , C12N15/90 , A61K35/17 , C07K14/47 , C07K14/725 , C12N5/0783 , C07K14/705 , C07K14/715 , C12N9/22 , C12N9/96 , C12N15/113 , C12N15/87
摘要: Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.
-
公开(公告)号:US20190054122A1
公开(公告)日:2019-02-21
申请号:US16180867
申请日:2018-11-05
申请人: REGENTS OF THE UNIVERSITY OF MINNESOTA , INTIMA BIOSCIENCE, INC. , The United States of America, as represented by the Secretary, Department of Health and Human
发明人: Branden Moriarity , Beau Webber , Modassir Choudhry , Steven A. Rosenberg , Douglas C. Palmer , Nicholas P. Restifo
IPC分类号: A61K35/17 , C12N15/90 , C07K14/47 , C07K14/705 , C07K14/725 , C12N9/96 , C12N9/22 , C12N5/0783 , C07K14/715 , C12N15/113 , C12N15/87
摘要: Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.
-
公开(公告)号:US20220105133A1
公开(公告)日:2022-04-07
申请号:US17481404
申请日:2021-09-22
申请人: Regents of the University of Minnesota , Intima Bioscience, Inc. , The U.S.A., as Represented by the Secretary, Department of Health and Human Service
发明人: Branden Moriarity , Beau Webber , Modassir Choudhry , Steven A. Rosenberg , Douglas C. Palmer , Nicholas P. Restifo
IPC分类号: A61K35/17 , C12N15/113 , C07K14/705 , C07K14/47 , A61P31/00 , A61P35/00 , A61K9/00 , C07K14/725 , C07K14/715 , C12N5/0783 , C12N9/22 , C12N15/79 , C12N15/90
摘要: Genetically modified compositions, such as non-viral vectors and tumor infiltrating lymphocytes, for the treatment of gastrointestinal cancer are disclosed. Disclosed are methods of utilizing a CRISPR system to generate genetically modified compositions. Also disclosed are the methods of making and using the genetically modified compositions for the treatment of gastrointestinal cancer.
-
公开(公告)号:US11925664B2
公开(公告)日:2024-03-12
申请号:US16900368
申请日:2020-06-12
申请人: Regents of the University of Minnesota , Intima Bioscience, Inc. , The U.S.A., as Represented by the Secretary, Department of Health and Human Services
IPC分类号: A61K48/00 , A61K35/17 , C07K14/47 , C07K14/705 , C07K14/715 , C07K14/725 , C12N5/0783 , C12N9/22 , C12N9/96 , C12N15/07 , C12N15/113 , C12N15/90 , C12N15/87
CPC分类号: A61K35/17 , C07K14/4718 , C07K14/70503 , C07K14/7051 , C07K14/7158 , C12N5/0636 , C12N9/22 , C12N9/96 , C12N15/113 , C12N15/907 , C12N15/87 , C12N2310/20 , C12N2510/00
摘要: Genetically modified compositions, such as non-viral vectors and T cells, for treating cancer are disclosed. Also disclosed are the methods of making and using the genetically modified compositions in treating cancer.
-
-
-
-
-
-
-
-
-